| NET LOSS PER SHARE |
20.
NET LOSS PER SHARE
Basic
and diluted net loss per share for each of the periods presented are calculated as follows:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended
December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | |
| | |
| | | |
| | | |
| | |
| Basic net loss per share | |
| | | |
| | | |
| | |
| Numerator: | |
| | | |
| | | |
| | |
| Net loss attributable to Uxin Limited | |
| (372,387 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| Deemed dividend to preferred
shareholders due to triggering of a down round feature | |
| (2,060,254 | ) | |
| - | | |
| - | |
| Net
loss attributable to ordinary shareholders | |
| (2,432,641 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | |
| Number of ordinary shares outstanding at the
beginning of the period | |
| 1,410,826,415 | | |
| 56,381,481,399 | | |
| 56,395,662,999 | |
| Weighted average number of ordinary shares issued | |
| 754,367,970 | | |
| 6,137,059 | | |
| 4,906,843,295 | |
| Weighted average number of vested penny options | |
| 20,169,250 | | |
| 29,241,834 | | |
| 22,577,368 | |
| Weighted average number
of unissued shares relating to the Performance Awards (Note 17) | |
| - | | |
| 327,882,355 | | |
| 1,431,232,500 | |
| Weighted average number of ordinary shares
outstanding - basic | |
| 2,185,363,635 | | |
| 56,744,742,647 | | |
| 62,756,316,162 | |
| | |
| | | |
| | | |
| | |
| Net loss per share attributable
to ordinary shareholders, basic | |
| (1.11 | ) | |
| (0.00 | ) | |
| (0.00 | ) |
| | |
| | | |
| | | |
| | |
| Diluted net loss per share | |
| | | |
| | | |
| | |
| Numerator: | |
| | | |
| | | |
| | |
| Diluted
net loss attributable to ordinary shareholders | |
| (2,432,641 | ) | |
| (204,312 | ) | |
| (277,540 | ) |
| | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | |
| Weighted average number of ordinary shares
outstanding – diluted | |
| 2,185,363,635 | | |
| 56,744,742,647 | | |
| 62,756,316,162 | |
| | |
| | | |
| | | |
| | |
| Net loss per share attributable
to ordinary shareholders, diluted | |
| (1.11 | ) | |
| (0.00 | ) | |
| (0.00 | ) |
UXIN
LIMITED
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All
amounts in thousands, except for share and per share data, unless otherwise noted)
20.
NET LOSS PER SHARE (CONTINUED)
As
the Group incurred losses for the fiscal year ended March 31, 2024, the nine months ended December 31, 2024 and the year ended December
31, 2025, the potential ordinary shares were anti-dilutive and excluded from the calculation of diluted net loss per share of the Group.
The weighted-average numbers of unissued shares relating to the Performance Awards, senior convertible preferred shares, options granted
and forward issued excluded from the calculation of diluted net loss per share of the Group of the respective periods were as follows:
SCHEDULE OF POTENTIAL ORDINARY SHARES THAT ARE ANTI-DILUTIVE AND EXCLUDED FROM THE CALCULATION OF DILUTED NET LOSS PER SHARE
| | |
For
the fiscal
year
ended
March
31, | | |
For
the nine
months
ended
December
31, | | |
For
the year
ended December
31, | |
| | |
2024 | | |
2024 | | |
2025 | |
| | |
| | | |
| | | |
| | |
| Unissued shares relating to the
Performance Awards (Note 17) | |
| - | | |
| 594,838,632 | | |
| - | |
| Forward contract | |
| - | | |
| 216,847,736 | | |
| 964,746,183 | |
| Senior convertible preferred shares | |
| 1,288,858,108 | | |
| - | | |
| - | |
| Outstanding weighted average share options | |
| 13,605,459 | | |
| 9,937,549 | | |
| 28,071,729 | |
| Total | |
| 1,302,463,567 | | |
| 821,623,917 | | |
| 992,817,912 | |
| Anti-dilutive securities excluded from the calculation of diluted net loss per share | |
| 1,302,463,567 | | |
| 821,623,917 | | |
| 992,817,912 | |
|